Erasca

IPO

To erase cancer.

Public · San Diego, United States · Founded 2018 · $300.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Website
erasca.com
Total Funding
$300.0M
Last Round
$236.0M Series BAug 2020
Rounds
2
Type
Public

About

Erasca is a clinical-stage precision oncology company co-founded in 2018 with a singular mission to erase cancer. The company develops novel therapies targeting the RAS/MAPK pathway, the most frequently altered signaling pathway in cancer, using small molecules, large molecules, and protein degraders in combination to comprehensively shut down oncogenic signaling across multiple tumor types.

Summary

Erasca is a Healthcare company based in San Diego, United States, founded in 2018. It has raised $300.0M in total across 2 rounds, most recently a $236.0M Series B round in Aug 2020. Investors include City Hill Ventures, Cormorant Asset Management and ARCH Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2020
$236.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Erasca on Indexed.vc
<a href="https://indexed.vc/companies/erasca"><img src="https://indexed.vc/api/badge/company/erasca" alt="Erasca on Indexed.vc" width="260" height="76" /></a>